跳至主要内容
临床试验/NCT06501105
NCT06501105招募中不适用

Clinical Study to Evaluate the Performance of WOUNDCHEK Bacterial Status

Woundchek Laboratories BV1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2024年6月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
75
试验地点
1
主要终点
Healing rate and mean percent wound area reduction

研究概览

简要总结

The purpose of this clinical study is to evaluate the performance of WOUNDCHEK™ Bacterial Status (WCBS) when the test result is used to inform treatment decisions.

详细描述

The clinician treating the wound will be allowed to use the test result in treatment decisions. The pretest treatment plan will be documented on the Case Report Form (CRF) prior to performing the WCBS test. After receiving the test result the clinician will document the post-test treatment plan. The healing outcome at 12 weeks following the test will be recorded on the CRF. The study will evaluate the healing outcomes compared to when test results are not used to assist in treatment decisions with study success defined as a higher healing rate and/or mean wound size reduction for WCBS positive wounds than obtained in the study PROT-2023-001. Also, the healing rate of wounds with a negative test result will be compared to the pretest rate to ensure that clinicians do not neglect and under treat this cohort with success criteria being that the WCBS negative wound healing rate is not worse than the pre-test healing rate. Additionally, the study will establish whether there are any device related Serious Adverse Events (SAEs) or Unanticipated Adverse Device Effects (UADEs).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject has presented to the participating study site with a VLU, DFU and / or a PU that is suspected not to be infected, as determined by the Investigator and/ or study staff - defined as one that does not show more than two of the NERDS signs of infection.
  • Subject is 18 years of age or older.
  • The wound is between 21 days and 6 months of age or more than 6 months of age if less than 1cm2 in area.
  • Subject agrees to complete all aspects of the study and provides written Informed Consent per IRB requirements.

排除标准

  • Subject does not meet inclusion criteria.
  • Target wound contains a malignancy.
  • Subject has hypersensitivity of the wound or painful wound surface which prevents touching/swabbing of the wound surface.
  • Subject is confirmed to be positive for HIV or hepatitis
  • Subject is unable or unwilling to provide informed consent.
  • A designated wound area may only be enrolled once in the study. For example, if an enrolled wound heals to complete closure and then re-opens, it cannot be re-enrolled in this study.

结局指标

主要结局

Healing rate and mean percent wound area reduction

时间窗: 12 weeks

Rate of healing and/or mean percent wound area reduction for WOUNDCHEK Bacterial Status positive wounds will be higher than obtained in the clinical study PROT-2023-001

次要结局

  • WOUNDCHEK Bacterial Status negative wound healing rate(12 weeks)
  • Adverse events(12 weeks)

研究者

发起方
Woundchek Laboratories BV
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验